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Normal cellular physiology is critically dependent on numerous mitochondrial activities
including energy conversion, cofactor and precursor metabolite synthesis, and regulation
of ion and redox homeostasis. Advances in mitochondrial research during the last two
decades provide solid evidence that these organelles are deeply integrated with the
rest of the cell and multiple mechanisms are in place to monitor and communicate
functional states of mitochondria. In many cases, however, the exact molecular nature
of various mitochondria-to-cell communication pathways is only beginning to emerge.
Here, we review various signals emitted by distressed or dysfunctional mitochondria and
the stress-responsive pathways activated in response to these signals in order to restore
mitochondrial function and promote cellular survival.
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INTRODUCTION
Mitochondria are semi-autonomous dynamic organelles of endosymbiotic origin involved in a
plethora of vital functions including energy conversion and synthesis of key precursor metabolites,
reducing equivalents, and cofactors. For more than half a century, mitochondria have been known
to the general audience as the “powerhouse of the cell” (Siekvitz, 1957). This scientific meme
refers to the organelle’s most commonly known bioenergetic function—generation of adenosine
triphosphate (ATP). This process commences by an uptake of substrates from the cytosol and is
followed by their catabolic conversion via fatty acid oxidation and/or the citric acid (TCA) cycle,
which yields reducing equivalents, nicotinamide adenine dinucleotide (NADH), and flavoadenine
dinucleotide (FADH2) as well as multiple biosynthetic precursors. The reducing equivalents
produced through the TCA cycle fuel the electron transport chain component of the mitochondrial
oxidative phosphorylation system (OXPHOS), wherein flow of electrons through respiratory
complexes is linked to generation of a proton gradient across the inner mitochondrial membrane
(IM) that is required for ATP production by F1F0 ATP synthase. Although these functions are
clearly crucial for cellular physiology and human health, the concept of mitochondria as isolated
biosynthetic and bioenergetic units is insufficient to explain certain phenotypic outcomes or clinical
manifestations associated with known mitochondrial dysfunctions.
The past two decades gave rise to tremendous research progress in the field of mitochondrial
biology. They provided a gamut of evidence that mitochondria are deeply integrated into cellular
physiology and metabolism. Mitochondria retain their own genome and transcription/translation
machineries; however, because they co-evolved with their host cell, a number of originally
mitochondrial genes have been transferred to the nucleus, thus contributing to the dual
genetic origin of the mitochondrial proteome. That is, the vast majority of proteins comprising
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the mitochondrial proteome is encoded by nuclear DNA,
synthesized in the cytosol, and is subsequently imported into the
organelle. This bi-genomic nature of themitochondrial proteome
necessitates tightly coordinated expression of bothmitochondrial
and nuclear genes to produce stoichiometric amounts of
its components to maintain proper organelle function. The
signaling mechanisms that assure such communication are
historically classified into anterograde and retrograde signaling.
The former mechanisms mediate coordination of mitochondrial
gene expression and—more broadly—mitochondrial function
in response to endogenous and environmental homeostatic
alterations sensed in the cytosol or by other organelles
(usually the nucleus). In turn, retrograde signaling mechanisms
monitor a variety of signals emitted by the mitochondria that
allow for communicating the functional state (e.g., levels of
energy production or the organelle’s biosynthetic capacity) of
mitochondria with other cellular compartments.
While much of the previous research focused on anterograde
signaling, recent advances highlight and greatly expand the
original paradigm postulated in the 1990’s (Butow and Avadhani,
2004), whereby mitochondria are viewed as critical signaling
hubs that take part in multiple cellular decisions. In this
review, we will focus on molecular signals produced by the
mitochondria to communicate homeostatic alterations and
coordinate retrograde responses. We will survey several diverse
groups of these signals including: (1) nucleotides; (2) precursor
metabolites; (3) free radicals; (4) peptides and polypeptides; and
(5) other molecules such as ions and lipids. Consequently, we




While the generation of ATP is undoubtedly one of the major
mitochondrial functions, mitochondria also provide some key
precursors to other nucleotides or nucleotide-based reducing
equivalents. It is therefore not surprising that cells have
developed sensitive mechanisms to monitor the levels of these
molecules and adjust cellular metabolic demands accordingly.
In this section, we will discuss how alterations in mitochondrial
or cellular levels of these mitochondria-borne molecules due
to mitochondrial dysfunction or distress are recognized as an
alarming signal to initiate a chain of events necessary to restore
cellular energy and metabolic homeostasis.
Adenylate Nucleotides
Generation of ATP through mitochondrial oxidative
phosphorylation is central to the maintenance of the optimal
ATP/adenosine diphosphate (ADP) ratios within the cell
(Figure 1). Under conditions of mitochondrial damage,
decreased ATP production results in depletion of intracellular
ATP, which leads to increased intracellular concentrations of
adenosine monophosphate (AMP) or its subsequent derivative,
adenosine. The latter nucleotide directly binds to the γ subunit of
the energy-sensing adenosine monophosphate-activated protein
kinase (AMPK) complex (Hardie et al., 2016). This regulatory
binding acts in concert with an upstream regulatory protein
kinase LKB1 to promote activation of AMPK (Pearce et al.,
2013; Hardie et al., 2016). AMPK is a key metabolic sensor in
the cell and its activation initiates multiple signaling events
leading to a series of interconnected processes: (1) inhibition of
ATP-dependent biosynthetic pathways to prevent wasteful use
of cellular ATP; (2) stimulation of ATP production via catabolic
reactions (Hall et al., 2013; Pearce et al., 2013); (3) activation
of autophagic removal of damaged mitochondria (mitophagy)
(Egan et al., 2011; Kim et al., 2011); and (4) metabolic re-
tuning of mitochondria via promotion of mitochondrial fission
(Toyama et al., 2016). These molecular events enable restoration
of cellular energy homeostasis and allow cells to cope with
metabolic distress.
Nicotinamide Adenine Dinucleotide
Nicotinamide adenine dinucleotide is a vital redox molecule
present in the cell in both oxidized (NAD+) and reduced
(NADH) forms. One distinctive feature of NAD+ is that cells
can utilize it as both a cofactor and a co-substrate (Canto et al.,
2015; Verdin, 2015). Cells maintain several NAD+ pools in
different cellular compartments; themitochondrial NAD+ pool is
segregated from the rest of the cell due to impermeability of the
mitochondrial inner membrane. Just like in the case of adenine
nucleotides, the NAD+/NADH equilibrium is central to normal
cellular function. In mitochondria, the optimal NAD+/NADH
and FADH/FADH2 ratios are primarily maintained through
OXPHOS function and the TCA cycle. In addition, the
cytosolic and mitochondrial NAD+ pools are connected
via malate/aspartate and glyceraldehyde-3-phosphate shuttles
that promote a mitochondria-cytosol exchange of reducing
equivalents (Birsoy et al., 2015; Verdin, 2015). Perturbations
of OXPHOS function decrease the NAD+/NADH ratio thereby
creating a deficit in mitochondria, and, ultimately, leading to
cytosolic NAD+/NADH imbalance (Birsoy et al., 2015; Sullivan
et al., 2015). Because glycolytic enzymes are NAD+-dependent,
respiratory compromised cells divert mitochondria-destined
pyruvate toward lactate production—the reaction that also yields
NAD+ for use in glycolysis. These actions can subsequently
activate AMPK- and MAP kinase-mediated downstream signal
transduction pathways (reviewed in Canto et al., 2015). Of note,
elevated cellular levels of lactate usually reflect mitochondrial
dysfunction and serve as a common diagnostic marker in patients
with mitochondrial disease (DiMauro and Schon, 2003; Vafai and
Mootha, 2012).
As mentioned above, NAD+ is also utilized as a co-substrate
by several different classes of enzymes including sirtuin protein
diacetylases—a group of versatile enzymes distributed across
subcellular compartments and involved in regulation of various
cellular activities such as histone modification and modulation of
master transcriptional regulators like forkhead box 03 (FOXO3),
nuclear factor kappa B (NF-κB), and peroxisome proliferator-
activated receptor gamma co-activator 1 alpha (PGC-1α, Canto
et al., 2015; Verdin, 2015). Alterations in cellular NAD+ levels
may, therefore, lead to substantial changes in the activity of
sirtuins and promote global transcriptional changes.
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FIGURE 1 | Mitochondria-derived metabolites regulate various cellular processes. Bioenergetic function of mitochondria is associated with generation of ATP
(adenosine triphosphate) via the oxidative phosphorylation (OXPHOS) system. This process involves conversion of various substrates imported from the cytosol via the
tricarboxylic acid (TCA) cycle or fatty acid oxidation (FAO). Metabolic intermediates can be exported into the cytosol to impact various signaling cascades.
Mitochondria-derived citrate is converted to oxaloacetate (OAA) and acetyl coenzyme A (Ac-CoA) by ATP citrate lyase (ACLY). Subsequently, a fraction of the cytosolic
Ac-CoA can be used in protein acetylation, thereby impacting multiple cellular processes (Choudhary et al., 2009; Spange et al., 2009; Wellen et al., 2009; Eisenberg
et al., 2014). Another TCA cycle biosynthetic intermediate, 2-ketoglutarate (α-KG), can be converted to 2-Hydroxyglutarate. This metabolite inhibits: (1) Jumonji C
domain-containing demethylases (JmjC), affecting epigenetic reprogramming (Pearce et al., 2013; Zong et al., 2016); and (2) hypoxia-inducible prolyl hydroxylases
(PHDs), thus stabilizing the hypoxia-inducible factors (HIFs) and inducing a hypoxic response (Xu et al., 2011; Pearce et al., 2013; Zong et al., 2016). The TCA
metabolite, fumarate, can also act as a signal-modulating factor via its ability to bind lysine residues of various proteins, resulting in a post-translational modification
called succinylation. The adenine nucleotide translocator (ANT) mediates an exchange of ATP and cytosol-derived ADP (adenosine diphosphate) across the inner
mitochondrial membrane (IM). Mitochondrial dysfunction derived ATP depletion perturbs ATP/ADP ratios by subsequent activation of adenosine
monophosphate-activated protein kinase (AMPK), a master regulator of cellular energy homeostasis (Hall et al., 2013; Pearce et al., 2013).
Other Nucleotides
Yet another nucleotide-based signaling mechanism is thought
to include the mitochondrial inner membrane-anchored enzyme
dihydroorotate dehydrogenase (DHODH), which oxidizes
dehydroorotate to produce orotate—the key precursor in
biosynthesis of pyrimidine nucleotides, uridine triphosphate,
and cytidine triphosphate (Evans and Guy, 2004). DHODH
activity is critically dependent on OXPHOS activity and the
presence of reduced ubiquinone as a direct electron acceptor.
As such, a dysfunctional OXPHOS stalls de novo synthesis
of pyrimidines, which in turn leads to stabilization and
nuclear accumulation of the tumor suppressor protein p53
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The mitochondrion is a source of several key metabolic
precursors utilized by cellular biosynthetic pathways. There
is growing evidence that mitochondria-produced intermediary
metabolites are not just mere biosynthetic building blocks, but
also potent regulators of various cellular signaling cascades.
In general, most, if not all, of the examples of mitochondrial
nucleotide-mediated signaling surveyed above can be viewed
from a metabolic sensing perspective. However, for the reader’s
convenience, we chose to discuss them separately. Here, we will
focus on TCA cycle-borne biosynthetic intermediates that may
exert signaling functions.
Acetyl Coenzyme A
Acetyl coenzyme A (Ac-CoA) is a central donor of two-
carbon units utilized in multiple biosynthetic reactions in the
mitochondrion. While Ac-CoA, per se, is unable to cross
mitochondrial membranes, its condensation with the four-
carbon TCA cycle intermediate oxaloacetate by citrate synthase
produces citrate that can be either utilized in subsequent
rounds of the TCA cycle or be readily exported out of the
mitochondria (Figure 1). In the cytosol, citrate is converted
back to oxaloacetate and Ac-CoA, which can be used in lipid
biosynthesis and protein acetylation. The latter post-translational
modification is mediated by lysine acetyltransferases and can
widely impact multiple cellular processes including signaling
(Choudhary et al., 2009; Spange et al., 2009; Wellen et al., 2009;
Eisenberg et al., 2014).
Interestingly, Ac-CoA and citrate metabolism-related
signaling have been in the spotlight for quite a long time. The
first retrograde response mechanism identified in respiratory
deficient yeast cells in 1990s invokes metabolic remodeling to
replenish mitochondrial glutamate, citrate, and Ac-CoA pools
(Liao and Butow, 1993; Liu and Butow, 1999). This apparently
yeast-specific pathway, known as the retrograde response gene,
or RTG pathway, includes a sensor protein, Rtg2, and two
transcriptional factors, Rtg1 and Rtg3 that are kept inactive
in the cytoplasm through phosphorylation. Mitochondrial
dysfunction appears to be sensed by Rtg2, which promotes
dephosphorylation and subsequent nuclear accumulation
of the Rtg1/Rtg3 tandem, thereby triggering transcriptional
responses. More details on the RTG pathway can be found in
the following reviews (Butow and Avadhani, 2004; Haynes et al.,
2013).
2-Ketoglutarate, Succinate, and Fumarate
Succinate, fumarate and 2-ketoglutarate are the four-carbon and
five-carbon metabolites of the TCA cycle, respectively. These
molecules can be exported to the cytosol through dicarboxylate
carrier proteins and utilized as the donors of carbon units
in a variety of biosynthetic reactions (Figure 1). However, in
certain mitochondrial dysfunctions—e.g., mutations affecting
the function of the TCA cycle enzymes isocytrate dehydrogenase,
succinate dehydrogenase, or fumarate hydratase—cells
accumulate these metabolites in both the mitochondria and
cytosol (Gaude and Frezza, 2014; Parker and Metallo, 2015;
Zong et al., 2016). Accumulation of 2-ketoglutarate (2-KG) is
associated with its conversion to 2-hydroxyglutarate (2-HG), a
potent mimetic, and inhibitor of 2-KG-dependent dioxygenases
in the cell—most notably hypoxia-inducible factor prolyl
hydroxylases (PHDs) (Xu et al., 2011; Pearce et al., 2013; Zong
et al., 2016) and the Jumonji-domain family histone lysine
demethylases (Jmj-KDMs) (Pearce et al., 2013; Zong et al., 2016).
Inhibition of these enzymes leads to significant epigenetic and
transcriptional changes (Pearce et al., 2013; Zong et al., 2016).
Additionally, 2-HG-mediated inhibition of PHDs stabilizes
hypoxia-inducible factors (HIFs), thereby activating hypoxic
signaling in the cell. It is therefore not surprising that 2-HG
is a recognized oncometabolite and its accumulation has been
reported in many cancers (Losman and Kaelin, 2013; Zong et al.,
2016).
Accumulation of succinate appears to have a similar
impact on function of PHDs and has been linked to
tumorigenesis (Zong et al., 2016). Accumulation of fumarate
results in the metabolite’s binding to lysine residues of various
proteins—so called succinylation (Zhang et al., 2011). Such
modifications negatively impact Kelch-like ECH associated
protein 1 (KEAP1)-nuclear factor erythroid-derived 2-like
(NRF2) signaling axis, wherein succinylation of KEAP1 leads
to stabilization of the transcriptional factor NRF2 that drives
antioxidant transcriptional responses (Adam et al., 2011, 2014).
The antioxidant peptide glutathione is yet another target for
succinylation—the modification depletes cellular GSH/GSSG
pools, which also results in activation of NRF2-mediated
antioxidant responses (Sullivan et al., 2013). Although seemingly
beneficial, sustained NRF2 activation may be detrimental to





Mitochondria-produced free radicals and their impact on
biological molecules have been extensively studied since the
1950’s. For decades, reactive oxygen species (ROS) and reactive
nitrogen species (RNS) have been recognized as key contributors
to cellular oxidative stress and are detrimental factors in many
pathologies and aging (Harman, 1972; Balaban et al., 2005;
Wallace, 2005). However, more recent studies established that
physiological amounts of free radicals are required to mediate a
number of normal cellular processes including several signaling
pathways such as hypoxic signaling (Finkel, 2011; Collins et al.,
2012; Sena and Chandel, 2012; Chandel, 2014; Shadel and
Horvath, 2015). Because a number of outstanding reviews are
available on this topic, in this section we will only highlight
several key aspects of ROS and RNS-mediated mitochondrial
signaling.
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Reactive Oxygen Species (ROS)
It is commonly accepted that the majority of cellular ROS
originates from mitochondrial energy metabolism (Murphy,
2009; Figueira et al., 2013). The flow of electrons through
ETC complexes is inevitably linked to a “leakage” of these
reducing equivalents, exposing them tomolecular oxygen. Partial
reduction of O2 yields the superoxide anion (O
·−
2 ); it is estimated
that ∼0.2–2% of O2 consumed by mitochondria is converted
to superoxide (Figueira et al., 2013). Additional factors, such as
full reduction of electron carriers (e.g., under the condition of
low ATP production) or elevated NAD+/NADH in the matrix
(e.g., due to OXPHOS damage), can further stimulate superoxide
production.
The two major sites for electron leakage are OXPHOS
complexes I and III (Figure 2). Electrons in Complex I leak from
the flavin mononucleotide site of the enzyme, thus producing
O·−2 on the matrix side of the mitochondrial inner membrane; in
the case of Complex III, superoxide is produced via the reactive
semiquinone intermediate on both matrix and intermembrane
space (IMS)-exposed sides of the enzyme (Murphy, 2009;
Figueira et al., 2013). The superoxide anion is a short-lived
free radical that is readily converted to hydrogen peroxide
(H2O2) by matrix-localized manganese (Mn-SOD, SOD2) or
copper-zinc (Cu-Zn SOD, SOD1) superoxide dismutase in
the IMS (Figure 2). Nonetheless, elevated levels of O·−2 may
impair the activity of Fe-S cluster-containing metabolic enzymes,
particularly aconitase, whose active site contains a surface-
exposed Fe-S cluster that is extremely vulnerable to oxidation
(Armstrong et al., 2004). Aconitase inactivation can lead to a
malfunctioning TCA cycle and accumulation of intermediary
metabolites such as citrate, which will in turn impinge on cellular
signaling as described in the previous section.
Unlike superoxide, H2O2 is a more stable molecule, which
can diffuse across mitochondrial membranes. It is thought to be
the primary ROS-related signal produced by the mitochondria
(Collins et al., 2012). Changes in cellular H2O2 may affect several
signaling-related processes. For instance, reversible oxidation
of specific redox-sensitive methionine residues can modulate
the activity of calcium/calmodulin-dependent protein kinase 2
(CaMK2), which controls global responses in excitable cells
such as cardiomyocytes (Erickson et al., 2008). Similarly, recent
data from the yeast genetic model indicate that elevated levels
of endogenous mitochondria-borne H2O2 can modulate the
activity of the target of rapamycin (TOR) complex 1 protein
kinase (TORC1) (Pan et al., 2011; Bohovych et al., 2016). These
data corroborate the results of the earlier in vitro analyses,
which suggested direct redox-modulation of TORC1 (Sabrassov
and Sabatini, 2005). Moreover, H2O2-triggered alterations in
the redox state of metal cofactor containing enzymes can
also initiate signaling responses. A well-established example of
such a mechanism is the modulation of hypoxic signaling by
mitochondria-derived H2O2 (Guzy et al., 2005; Hamanaka and
Chandel, 2010; Sena and Chandel, 2012).
The stability of H2O2, its ability to traverse cellular
membranes, and its propensity to oxidize thiol groups of
surface-exposed, low-pKa cysteine residues under physiological
conditions makes hydrogen peroxide-mediated post-
translational modifications an important molecular event
underpinning a wide range of signaling processes in the cell.
The selective reactivity of H2O2 with key cysteine residues of
redox-active GTPases, transcription factors, proteases, receptors,
kinases, phosphatases, and protein disulfide isomerases can
alter the target protein’s activity, conformation, or subcellular
localization, thereby modulating cellular signal cascades
and outputs (reviewed in García-Santamarina et al., 2014;
Russell and Cotter, 2015). The reversibility of thiol oxidation
(sulfenylation) reactions is assured through the function of
electron donor proteins such as thioredoxins, glutaredoxins,
and sulfiredoxins, which can all efficiently reduce oxidized
cysteines, thus reversing the modulatory effect of thiol oxidation
(Brandes and Jakob, 2009). For instance, protein tyrosine
phosphatases (PTPs) are among the best-studied components
of H2O2-regulated signal transduction in mammalian cells.
Initial evidence of sulfenic acid intermediate formation in
response to low micromolar concentrations of H2O2 in three
different PTPs (PTP1, leukocyte antigen-related phosphatase
LAR, and vaccinia H1-related phosphatase VHR) was originally
reported by Denu and Tanner (1998). Inactivation of the PTPs
caused by sulfenylation of the catalytic cysteine can then be
followed by secondary modifications like formation of disulfide
bonds or sulfenyl amide linkages for further protection against
overoxidation (Tanner et al., 2011). An interesting example of
redox regulation involving non-catalytic cysteines was described
of the human lymphoid tyrosine phosphatase (LYP). Upon
oxidizing conditions, a disulfide bond is formed between the
catalytic cysteine residue (Cys-227) and the cysteine residues
outside of the signature motif (Cys-129) (Tsai et al., 2009). To
prevent malproductive reactivation in the reducing environment,
Cys-227 forms a disulfide bond with yet another non-catalytic
Cys-231, suggesting the possibility of an autoregulatory circuit
(Tsai et al., 2009). Multiple outstanding reviews are available
on sulfenylation-based activity modulation in various protein
kinases (Corcoran and Cotter, 2013; Truong and Carroll,
2013; Russell and Cotter, 2015). The examples include, but
are not limited to, the signaling cascades of receptor tyrosine
kinases (RTKs), the serine-threonine protein kinase, Akt,
mitogen-activated kinases (MAP kinases), cytoplasmic Src
(c-Src), inhibitory κB kinases (IKK), and the c-AMP-dependent
protein kinase. It should be noted, however, that in many
of the aforementioned cases it remains to be determined
whether these H2O2-signaling events involve mitochondria-
derived ROS. To date, mitochondria-produced H2O2 has been
implicated in Akt/phosphoinositide-3-kinase (PI3K) signaling
via sulfenylation-mediated inactivation of the phosphatase
PTEN (Connor et al., 2005). Another example includes the
recently described activation of two mitochondria-localized
kinases, the Src family tyrosine kinase, Lyn, and the spleen
tyrosine kinase, Syk, by mitochondrial ROS (Patterson et al.,
2015). Activation of these kinases is important for the proper
functioning of several signaling cascades including that of the
mitogen-activated protein kinases JNK and Akt (Patterson et al.,
2015).
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FIGURE 2 | Impact of mitochondria-derived free radicals on cellular signaling processes. Reduction of molecular oxygen to the superoxide anion (O·−2 ) is an
unavoidable consequence of electron leakage associated with the bioenergetic function of respiratory complexes (Figueira et al., 2013). The O·−2 produced is quickly
converted to hydrogen peroxide (H2O2) by the mitochondrial matrix-associated manganese (SOD2) or inner membrane space (IMS)-localized copper-zinc (SOD1)
superoxide dismutases (Murphy, 2009; Figueira et al., 2013). Accumulation of H2O2 can affect functioning of mitochondrial proteins, in particular those containing
iron-sulfur clusters. Aconitase, a key component of the TCA cycle, is one of the mitochondrial proteins most susceptible to oxidative damage due to the surface
exposed iron-sulfur cluster-containing active sites (Armstrong et al., 2004). Mitochondria-derived O·−2 and H2O2 can also impact cytosolic signaling cascades via
oxidation of various redox-sensitive proteins including calcium/calmodulin-dependent protein kinase 2 (CaMK2) (Erickson et al., 2008), the mammalian target of
rapamycin complex 1 protein kinase (mTORC1), and PHD hydroxylases (Sena and Chandel, 2012). The cytosol-derived nitric oxide radical (NO.), a product of arginine
conversion by nitric oxide synthases (NOSs), can permeate mitochondrial membranes and inhibit electron transport chain functioning through competitive inhibition of
respiratory complex IV or via condensation with O·−2 and formation of a potent oxidant, peroxynitrate (ONOO
−) (Nisoli et al., 2003; Antunes et al., 2004; Figueira et al.,
2013).
Reactive Nitrogen Species (RNS)
The nitric oxide radical (NO.) is probably the best-characterized
type of RNS. Although mitochondrial origin of NO. remains
debated, it is clear that this stable free radical is able to cross
mitochondrial membranes and exert several modulatory effects
pertinent to mitochondrial signaling (Figure 2). Elevated levels
of mitochondrial NO. may alter the mitochondrial bioenergetics
status via inhibition of OXPHOS by competing with molecular
oxygen for respiratory Complex IV, thereby affecting the cellular
ATP/ADP ratio or driving excessive production of superoxide
by the ETC (Nisoli et al., 2003; Antunes et al., 2004; Figueira
et al., 2013). NO may also drive reversible modification (S-
nitrosylation) of specific protein thiols to S-nitrosothiols. Such
posttranslational modifications are shown tomodulate properties
of multiple signaling pathways including those of HIFα and
NF-κB (Hess et al., 2005; Nakamura et al., 2013).
Finally, NO. can interact with mitochondrial superoxide and
form yet another potent RNS, peroxynitrate (ONOO−), which




The vast majority of polypeptides comprising the mitochondrial
proteome are produced by cytosolic translation; newly
synthesized polypeptides are imported into the organelle in an
unfolded state (Neupert and Herrmann, 2007; Chacinska et al.,
2009). However, several core hydrophobic subunits of OXPHOS
complexes are produced by mitochondrial translation machinery
and need to be stoichiometrically paired with imported
polypeptides. This complex nature of the mitochondrial
proteome creates a challenging protein folding environment;
therefore, it is not surprising that synthesis and assembly of
mitochondrial proteome components is a well-orchestrated
and highly regulated process (Couvillion et al., 2016). In
addition, a large number of metabolic enzymes in the matrix
are prone to facile aggregation (Bender et al., 2011). Conditions
of mitochondrial stress may perturb stoichiometric equilibrium
and cause an accumulation of unassembled and/or misfolded
proteins in various mitochondrial sub-compartments and reduce
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mitochondrial import. Such alterations in mitochondrial protein
homeostasis (proteostasis) can be communicated via several
mechanisms highlighted below. Furthermore, we will discuss
how several mitochondrial polypeptides signal the initiation of
an apoptotic program when mitochondrial damage exceeds the
repair capacities of a cell.
Mitochondrial Unfolded Protein Response
(UPRmt)
One of the best-understood responses to mitochondrial
proteostatic stress is the mitochondrial unfolded protein
response (UPRmt). Activation of UPRmt in higher eukaryotes
induces the transcription of genes involved in protein folding
and quality control (Pellegrino et al., 2013; Bohovych et al.,
2015; Topf et al., 2016), metabolism (Lin and Haynes, 2016), and
mtDNA maintenance (Lin et al., 2016). Reciprocally, UPRmt
induction is linked to an inhibition of the genes related to both
the TCA cycle and OXPHOS components (Nargund et al.,
2015). Two key molecular facets of UPRmt were gleaned from
studies in the roundworm Caenorhabditis elegans genetic model
(Figure 3). One aspect involves generation of signaling peptides
produced through proteolytic processing of unassembled
or misfolded polypeptides by the matrix peptidase ClpXP
(Haynes et al., 2010). The peptides are subsequently extruded
from mitochondria into the cytosol via the HAF-1 peptide
exporter and subsequently activate UPRmt by an unknown
mechanism (Haynes et al., 2010, 2013). Another, likely more
prominent, component of UPRmt in nematodes is represented
by the versatile bZip activating transcription factor associated
with stress 1 (ATFS-1) equipped with both a mitochondrial
targeting sequence and a nuclear localization signal (Haynes
et al., 2010; Nargund et al., 2012). Under normal conditions,
ATFS-1 is targeted to mitochondria and inactivated through
degradation by the LON protease. However, under conditions
of mitochondrial stress that attenuate protein import into the
organelle, a portion of AFTS-1 relocates to the nucleus. It was
recently reported that UPRmt-associated chromatin remodeling
allows nuclear ATFS-1 to bind targeted sequences (Tian et al.,
2016) and promote expression of more than 400 genes encoding
for proteins involved in mitochondrial proteostasis, metabolism,
and innate immunity (Lin and Haynes, 2016).
UPRmt activation in mammalian cells is less understood. It
appears to be more complex and stochastic and is achieved via
a complex signaling cascade requiring sequential activation of
the c-Jun N-terminal kinase, a component of AP-1 transcription
factor c-Jun, and finally transcription factors C/EBPβ and C/EBP
homologous protein (CHOP) (Pellegrino et al., 2013; Topf et al.,
2016), which enhance the expression of so-called canonical
UPRmt genes, including those that encode mitochondrial
chaperones and proteases (Aldridge et al., 2007; Horibe and
Hoogenraad, 2007). Interestingly, a recent study by Seiferling
et al. (2016) demonstrated that CLPP appears to play no role in
mammalian UPRmt activation.
The other, likely related to the UPRmt, responses reported
in mammals include HTRA2 protease-mediated response in the
brain (Moisoi et al., 2009) and the StAR accumulation response
in steroidogenic cells (Bahat et al., 2014, 2015). The former is
a brain-specific transcriptional response caused by the loss of
HTRA2 in neuronal cells and a subsequent respiratory defect
and accumulation of unfolded proteins in the mitochondria of
these cells (Moisoi et al., 2009). The StAR overload response is
triggered by elevated levels of the steroidogneic acute regulatory
protein (StAR) in the mitochondrial matrix and promotes
expression of several mitochondrial proteases to counter the
accumulation of this protein within the mitochondria (Bahat
et al., 2014, 2015). The molecular aspects of these responses are
yet to be clarified.
Unfolded Protein Response Activated by
Protein Mistargeting (UPRam)
Abnormal accumulation of mitochondrial precursor
polypeptides was recently linked to activation of stress
responsive pathways in the cytosol (Topf et al., 2016). Two
recent publications reported a novel type of mitochondrial
proteostatic response termed mPOS (mitochondrial precursor
over-accumulation stress) (Wang and Chen, 2015; Wrobel et al.,
2015). The mPOS is associated with defects in mitochondrial
import machinery, and inner membrane integrity and function.
The response appears to modulate two distinct cellular activities:
(1) cytosolic protein synthesis; and (2) an unfolded protein
response activated by protein mistargeting (so-called UPRam).
The latter significantly differs from the canonical mitochondrial
unfolded protein response (UPRmt), a pathway triggered by
impaired mitochondrial proteostasis (Wrobel et al., 2015).
Protein synthesis regulation by mPOS involves a global increase
in cap-independent translation (and reciprocal reduction of
cap-dependent translation), as well as modulation of ribosomal
biogenesis (Wang and Chen, 2015; Wrobel et al., 2015). The
signaling mechanisms underpinning these events remain to be
determined.
A similar modulation of protein biogenesis is also related to
antibiotic-induced defects in mitochondrial translation. Stalling
of mitochondrial ribosomes in mouse embryonic fibroblasts
by treatment with the mitochondrial translation inhibitor,
actinonin, activates cellular proliferation signaling pathways such
as that of p53 and MAP kinase (Richter et al., 2013).
PINK1-Parkin Signaling Relay
Higher eukaryotes possess yet another elegant mechanism
to signal mitochondrial distress and promote removal of
dysfunctional mitochondria via selective autophagy (mitophagy).
This mechanism, known as the PINK1-Parkin relay (Figure 4),
composed of the phosphatase and tensin homolog (PTEN)-
induced ubiquitin kinase 1 (PINK1) and the E3 ubiquitin ligase
Parkin, mediates poly-ubiquitylation of damaged mitochondria
thereby priming mitophagy (Sarraf et al., 2013; Lazarou et al.,
2015). Similar to ATFS-1, PINK1 is imported into mitochondria
under normal conditions, wherein the protein is promptly
degraded by the IM resident presenilin associated rhomboid-like
protease (PARL) (Jin et al., 2010). Conditions of mitochondrial
stress that perturb protein import into the organelle cause the
stabilization and accumulation of PINK1 on the mitochondrial
outer membrane (OM), where this kinase drives phosphorylation
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FIGURE 3 | The mitochondrial unfolded protein response (UPRmt). Activation of UPRmt in response to mitochondrial damage is best characterized in the
roundworm Caenorhabditis elegans, where it is regulated by the activating transcription factor associated with stress 1 (ATFS-1). In the absence of stress stimuli,
ATFS1 is transported to the mitochondria and degraded by LON protease (Nargund et al., 2012). Conditions of mitochondrial stress stall mitochondrial import of
ATFS-1, allowing a fraction of the protein to translocate into the nucleus and promote expression of more than 400 mitochondrial homeostasis-related genes (Lin and
Haynes, 2016). Another, not-so-well defined, activation of UPRmt in C. elegans is associated with peptide exporter HAF-1, which translocates signaling peptides
generated by the matrix peptidase ClpXP (Haynes et al., 2010).
of Parkin as well as ubiquitin (Kondapalli et al., 2012; Kane et al.,
2014; Kazlauskaite et al., 2014; Koyano et al., 2014; Ordureau
et al., 2014). These actions promote: (1) mitochondrial retention
of Parkin (Ordureau et al., 2014); (2) subsequent assembly of
poly-ubiquitin chains on various OM proteins (Sarraf et al.,
2013); and (3) activation of autophagosome-stimulating protein
TANK-binding kinase 1, TBK1 (Heo et al., 2015). Of note,
genetic mutations in the components of this pathway have been
linked to familial cases of neurodegenerative diseases such as
Parkinson’s disease (Pickrell and Youle, 2015) and amyotrophic
lateral sclerosis (Maruyama et al., 2010; Wong and Holzbaur,
2014; Cirulli et al., 2015).
Interestingly, the recently described mitochondria-derived
vesicles (MDV) quality control pathway that appears to mediate
crosstalk between mitochondria and either peroxisomes or
lysosomes (Neuspiel et al., 2008; Sugiura et al., 2012) also seems
to rely on the mitophagy-independent function of the PINK1-
Parkin relay (Sugiura et al., 2012).
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FIGURE 4 | The PINK1-Parkin signaling relay. Under physiological conditions, phosphatase and tensin homolog (PTEN)-induced ubiquitin kinase 1 (PINK1), a key
regulator of mitophagy and mitochondrial turnover, is imported into the mitochondria via the translocases of outer (TOM) and inner (TIM) membranes. It is
subsequently degraded by presenilin associated rhomboid-like protease (PARL) in the IM (Jin et al., 2010). However, in response to mitochondrial damage, stabilized
PINK1 accumulates on the outer membrane (OM), promoting recruitment, and activation of the E3 ubiquitin ligase parkin, followed by ubiquitylation of OM-associated
proteins, and initiation of mitophagy (Kondapalli et al., 2012; Kane et al., 2014; Kazlauskaite et al., 2014; Koyano et al., 2014; Ordureau et al., 2014). More details are
available in the text.
Cytochrome c
Mitochondria are intimately involved in the control of
apoptotic signaling cascades. In particular, initiation of
apoptosis is associated with release of the IM and IMS
proteins such as cytochrome c, apoptosis inducing factor AIF,
second mitochondria-derived activator of caspase protein
(SMAC), serine protease high temperature requirement
protein A2 (HTRA2), and endonuclease G. Upon their
release from irreversibly damaged mitochondria through
the β-cell CLL/lymphoma 2 (Bcl2) family proteins-mediated
mitochondrial outer membrane permeabilization, these proteins
serve as signaling molecules to regulate and propel cell death
processes (Tait and Green, 2010).
The small nuclear-encoded electron carrier cytochrome c
plays one of the key roles in programmed cell death—its release
is a critical event necessary to initiate an apoptotic program
(Liu et al., 1996; Hüttemann et al., 2011). This rapid feed-
forward process commences with disassociation of cytochrome c
from its complexes with the mitochondria-specific phospholipid
cardiolipin following the protein’s detachment from the IM
(Goldstein et al., 2000; Ott et al., 2002; Garrido et al., 2006).
While cytochrome c-independent forms of cell death have been
reported (e.g., see the review by Sevrioukova, 2011), here we will
focus on mitochondrial signaling via this molecule.
Accumulation of released cytochrome c in the cytosol
triggers the formation of the apoptosome—a wheel-like structure
containing seven molecules of apoptotic protease-activating
factor 1 (APAF-1) equaled by cytochrome c. The apoptosome
complex activates the key apoptotic factor, caspase 9, which
subsequently promotes the execution of the apoptotic program
(Reubold and Eschenburg, 2012). Of note, cytochrome c-induced
caspase activation is not always associated with cell death.
Examples of the vital processes requiring cytochrome c release
include platelet formation, β-cell proliferation, and monocyte-
macrophage differentiation (Garrido et al., 2006). Similarly,
in Drosophila melanogaster, cytochrome c serves as a crucial
signaling molecule in caspase-mediated sperm cell development
(Nagata, 2016).
Mitochondria-Derived Peptides
Just like in bacteria, the initiation of mitochondrial translation
requires N-formylmethionine-tRNA (Ott et al., 2016).
Mitochondria-derived N-formylated peptides have long been
known as potent chemoattractants for neutrophils (Carp, 1982).
Further studies demonstrated binding of the polymorphonuclear
neutrophils (PMN)-expressed formyl peptide receptors (FPRs)
by native and synthetic peptides originated from mitochondrial
Complex I subunits 4 and 6, Complex IV subunit 1 (Rabiet
et al., 2005), and cytochromes b (Mukai et al., 2009; Seki et al.,
2011) and c (Hokari et al., 2012). Subsequent activation of FPRs
involves multiple signaling cascades controlling calcium flux, p38
kinase activation, and cytokine production (Rabiet et al., 2007).
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It is noteworthy that the release of formylated mitochondrial
peptides following trauma is associated with inflammation, thus
potentially linking injury to non-infective systemic inflammatory
response syndrome and sepsis (Zhang et al., 2010).
The mammalian mitochondrial genome is known to encode
only 11 proteins (Ott et al., 2016). However, this number might
be extended due to the recent discovery of short open reading
frames (sORFs), which encode so-called mitochondrial-derived
peptides (MDPs) (Lee et al., 2016). Perhaps the best-characterized
MDP is a 24-amino acid long peptide named humanin—which
was originally shown to bind to the pro-apoptotic factor Bax in
a manner similar to that of its nuclear-borne homolog; therefore
suggesting a potential regulatory role in cell death (Guo et al.,
2003). More detailed reviews of various humanin-associated
cytoprotective effects can be found elsewhere (Lee et al., 2013).
Another MDP called MOTS-c (mitochondrial open reading
frame of the 12S rRNA-c) was discovered more recently. The
activity of this 16-amino acid long peptide has been linked to the
regulation of muscle energy expenditure and insulin sensitivity.
MOTS-c activates a metabolic/signaling axis comprised of the
one-carbon folate cycle and AMPK, thereby providing an
obesity-protective effect (Lee et al., 2015). Interestingly, the most
recent study by Cobb et al. (2016) reported identification of
six sORFs originating from the same genetic locus as humanin
which have been named small humanin-like peptides (SHLPs).
The signaling roles of SHLPs remain to be elucidated.
OTHER MITOCHONDRIA-DERIVED
SIGNALS
In this section, we will survey several additional molecules that
cannot be placed into any of the above groups of mitochondria-
borne signals. This does not imply that the following molecules
are not linked to the pathways described above. Likewise, these
signals do not appear to function on their own and are well
intertwined with the signals described above and with each
other. For instance, signaling via changes in mitochondrial
and intracellular calcium levels is linked to ROS-mediated
communication, as well as signals arising from defects in the
mitochondrial genome.
Calcium Ions
The mitochondria can be viewed as an efficient Ca2+ sink
that assists the endoplasmic reticulum (ER) and lysosomes in
control of cellular metabolism and death via apoptosis, necrosis,
and autophagy (Rizzuto et al., 2012). Active flux of Ca2+
between the ER and mitochondria is driven via the mammalian
mitochondria-associated membranes (MAMs) or yeast’s ER-
mitochondria encounter structures (ERMES). A decrease of
Ca2+ levels in the mitochondria leads to a rapid drop in
ATP production, followed by activation of the AMPK signaling
pathway, resulting in subsequent initiation of autophagy (La
Rovere et al., 2016). Conversely, mitochondrial Ca2+ overload
promotes opening of the mitochondrial permeability transition
pore (mPTP), a non-specific transporting channel in the IM
resulting in mitochondrial membrane depolarization, swelling,
OM rupture, and release of IM and IMS residing pro-apoptotic
factors (Bhosale et al., 2015; Takeuchi et al., 2015). Increased
levels of Ca2+ in the cytosol can activate various soluble Ca2+-
binding proteins such as calmodulin, which in turn can bind to
various targets including calmodulin-dependent CaMK protein
kinases, myosin light chain kinase MLCK, and calcinuerin—the
key regulators of a plethora of cellular processes (Tidow and
Nisse, 2013). Of note, excessive accumulation of Ca2+ and failure
to clear cytoplasmic Ca2+ have been linked to necrosis initiation
(Rizzuto et al., 2012).
Mitochondrial DNA and Replication
Defects
The first insights into the impact of mitochondrial DNA
(mtDNA) depletion or lesions on nuclear gene expression in
mammalian cells were reported by Avadhani’s lab in the late
1990’s and linked these defects to decreased Ca2+ buffering
capacity of the mitochondria and ultimately cytosolic calcium
accumulation (Biswas et al., 1999; Amuthan et al., 2001). As
outlined in the previous section, elevated levels of cytosolic
Ca+2 trigger the activation of calcineurin and downstream
transcriptional factors such as NF-κB, CHOP, and extracellular
signal-regulated kinase 1 (ERK1) (Butow and Avadhani, 2004).
mtDNA, with its circular loop and numerous regions of non-
methylated DNA (CpG islands), partially resembles bacterial
genomes (Fang et al., 2016). Similar to bacterial pathogen-
associated molecular patterns, mtDNA along with formylated
peptides (see above) has been described as mitochondria-derived
damage-associated molecular patterns (DAMPs) that are capable
of PMNs stimulation via Toll-like receptor 9 (TLR9) and,
subsequently, the p38 MAP kinase signaling cascade (Zhang
et al., 2010). In addition, accumulation of mtDNA in the cytosol
can activate the DNA-specific sensor, cGAS, which promotes
signal transduction via the STING-TBK1-interferon regulatory
factor 3 (IRF3)-dependent pathway, thereby increasing
interferon-stimulated gene expression. This chain of events
ultimately results in activation of an antiviral immune response
(West et al., 2015). Under apoptotic conditions, oxidized
mtDNA also appear to activate nucleotide-binding domain
leucine-rich repeat family, pyrin domain containing 3 (NLRP3)
inflammasome, and IL-1β production (Shimada et al., 2012). It
is noteworthy that the NLRP3 inflammasome itself is associated
with mitochondria through its interactions with mitochondrial
antiviral signaling protein MAVS, mitochondrial OM GTPases
mitofusins, caspase-like apoptosis regulatory protein c-FLIP, and
the phospholipid cardiolipin (Elliot and Sutterwala, 2015).
mtDNA maintenance and replication requires a complex
network of factors encoded by both the nuclear and the
organelle’s genomes (Ott et al., 2016). Mutations leading to
the depletion of mtDNA have a profound effect not only on
mitochondrial health, but also on the overall course of various
diseases in human patients (Young and Copeland, 2016). For
instance, mutated forms of the mtDNA helicase, TWINKLE,
are associated with mitochondrial myopathy (MM) and infantile
onset spinocerebellar ataxia (IOSCA). Mouse models for MM
and IOSCA display a significant number of mtDNA replication
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defects upon modulation of purine and serine/glutathione
biosynthesis (Nikkanen et al., 2016). Previous studies in the
late-onset MM mouse model also demonstrated a fasting-like
transcriptional response via the AKT1-PI3K signaling cascade
upon disease progression. Particularly, increased production of
the starvation-associated fibroblast growth factor 21 (Fgf21) was
detected in themutation-carrying animals, which, in turn, caused
profound changes to lipid metabolism, including resistance to
high-fat diet (Tyynismaa et al., 2010). CHOP10 is another
transcription factor activated upon defective mtDNA expression.
However, this response does not appear to be associated with the
UPRmt and is likely a manifestation of a general stress response
(Michel et al., 2015).
Cardiolipin
Cardiolipin (CL) is a unique non-bilayer phospholipid specific
to mitochondrial membranes. Mounting evidence indicates
that CL contributes to a plethora of mitochondrial processes
including signaling events required to initiate mitophagy and
apoptotic cell death (Lu and Claypool, 2015). Under normal
physiological conditions, CL is almost exclusively localized to
the IM. However, mitochondrial stress stimuli trigger random
CL translocation to the OM, and this event serves as a signal
to activate the autophagy machinery via CL binding to its
central component, microtubule-associated protein 1 light chain
3 (LC3) (Chu et al., 2013; Kagan et al., 2015). Mitophagy-
specific induction by CL requires the phospholipid’s remodeling
by tafazzin, an evolutionary conservedmonolyso-CL transacylase
(Hsu et al., 2015). Mutations in tafazzin are linked to the human
multisystemic disorder, Barth syndrome (Lu andClaypool, 2015).
Studies in lymphoblastoid cells from Barth syndrome patients
reveal an important role for CL in the translocation of the
pro-apoptotic protease, caspase 8 (Gonzalvez et al., 2008).
Release of mitochondria-associated pro-apoptotic factors is
believed to require selective CL oxidation by cytochrome c
(Kagan et al., 2005; Choi et al., 2007); in vitro experiments suggest
that cytochrome c might acquire its peroxidation activity upon
interaction with the phospholipid (Basova et al., 2007). The CL-
mediated decision (mitophagy vs. apoptosis) likely depends on
the extent of CL externalization (Lu and Claypool, 2015).
Finally, CL is implicated as a potent immunogenic factor.
First, it is capable of activating the NLRP3 inflammasome
via direct binding to the NLRP3 component. As such, this
event leads to caspase 1 activation and further production of
the proinflammatory cytokines, IL-1β, and IL-18 (Iyer et al.,
2013). Another exciting aspect is the ability of liposomes
and mitochondria with CL-containing surfaces to be efficiently
recognized and engulfed by macrophages in a CD36-dependent
manner in vitro (Balasubramanian et al., 2015). It will be
interesting to ascertain if a similar process occurs in vivo.
CONCLUDING REMARKS
In this review, we have surveyed several mitochondrial signals
that regulate the organelle’s biogenesis and stress-response
pathways. One cannot help but notice that a number of these
signals and responses appear to be triggered by similar, if
not the same, homeostatic insults. How mitochondria-borne
signals are interrelated, and if there is any signaling hierarchy,
remains to be clarified. It will be important to gain further
mechanistic understanding into howmitochondrial stress signals
are propagated and transferred. Because a number of the insights
described above were gleaned from studies inmodel organisms or
in vitro cell cultures, it will be equally important to determine the
extent and magnitude of such signaling responses in organs and
tissues. These findings may help to better understand a tissue-
specific nature of certain mitochondria-related pathologies.
Another exciting question is whether these signals can be
manipulated to increase mitochondrial stress tolerance and
achieve therapeutic benefits in mitigating disease-related states
or extending lifespan. In that respect, recent findings such
as NAD+ repletion-mediated improvement of mitochondrial
function and lifespan in mice (Zhang et al., 2016) or potential
therapeutic effects of hypoxic preconditioning in the rodent
model of mitochondrial disease (Jain et al., 2016), as well as
ones of mitochondria-targeted antioxidants in the murine model
of Huntington’s disease (Xun et al., 2012) are encouraging and
create a solid premise for future translational studies. Likewise,
targeting mitochondrial signals or signaling pathways emerges
as a prospective theranostic paradigm in treatment of various
cancers (Zong et al., 2016).
AUTHOR CONTRIBUTIONS
IB analyzed the literature and co-wrote the manuscript. OK
conceived the idea, analyzed the literature, co-wrote the
manuscript, and designed the figures.
ACKNOWLEDGMENTS
We apologize to those authors whose work we were unable
to cite due to space limitations. We thank members of the
Khalimonchuk laboratory for useful discussions and edits. OK is
supported by the NIH grants R01 GM108975 and P30 GM103335
(to Nebraska Redox Biology Center).
REFERENCES
Adam, J., Hatipoglu, E., O’Flaherty, L., Ternette, N., Sahgal, N., Lockstone, H.,
et al. (2011). Renal cyst formation ih Fh1-deficient mice is independent of the
Hif/Phd pathway: roles for fumarate in KEAP1 succination and Nrf2 signaling.
Cancer Cell 20, 524–537. doi: 10.1016/j.ccr.2011.09.006
Adam, J., Yang, M., Soga, T., and Pollard, P. J. (2014). Rare insights into cancer
biology. Oncogene 33, 2547–2556. doi: 10.1038/onc.2013.222
Aldridge, J. E., Horibe, T., and Hoogenraad, N. J. (2007). Discovery
of genes activated by the mitochondrial unfolded protein response
(mtUPR) and cognate promoter elements. PLoS ONE 2:e874. doi:
10.1371/journal.pone.0000874
Amuthan, G., Biswas, G., Zhang, S. Y., Klein-Szanto, A., Vijayasarathy, C., and
Avadhano, N. G. (2001). Mitochondria-to-nucleus stress signaling induces
phenotypic changes, tumor progression and cell invasion. EMBO J. 20,
1910–1920. doi: 10.1093/emboj/20.8.1910
Frontiers in Cell and Developmental Biology | www.frontiersin.org 11 October 2016 | Volume 4 | Article 109
Bohovych and Khalimonchuk Mitochondria-Mediated Signaling
Antunes, F., Boveris, A., and Cadenas, E. (2004). On the mechanism and biology
of cytochrome oxidase inhibition by nitric oxide. Proc. Natl. Acad. Sci. U.S.A.
101, 16774–16779. doi: 10.1073/pnas.0405368101
Armstrong, J. S., Whiteman, M., Yang, H., and Jones, D. P. (2004). The redox
regulation of intermediary metabolism by a superoxide-aconitase rheostat.
Bioessays 26, 894–900. doi: 10.1002/bies.20071
Bahat, A., Perlberg, S., Melamed-Book, N., Isaac, S., Eden, A., Lauria, I., et al.
(2015). Transcriptional activation of LON gene by a new form of mitochondrial
stress: a role for the nuclear respiratory factor 2 in StAR overload response
(SOR).Mol. Cell. Endocrinol. 408, 62–72. doi: 10.1016/j.mce.2015.02.022
Bahat, A., Perlberg, S., Melamed-Book, N., Lauria, I., Langer, T., and Orly, J.
(2014). StAR enhances transcription of genes encoding the mitochondrial
proteases involved in its own degradation. Mol. Endocrinol. 28, 208–224. doi:
10.1210/me.2013-1275
Balaban, R. S., Nemoto, S., and Finkel, T. (2005). Mitochondria, oxidants, and
aging. Cell 120, 483–495. doi: 10.1016/j.cell.2005.02.001
Balasubramanian, K., Maeda, A., Lee, J. S., Mohammadyani, D., Dar, H. H., Jiang, J.
F., et al. (2015). Dichotomous roles for externalized cardiolipin in extracellular
signaling: Promotion of phagocytosis and attenuation of innate immunity. Sci.
Signal. 8:ra95. doi: 10.1126/scisignal.aaa6179
Basova, L. V., Kurnikov, I. V., Wang, L., Ritov, V. B., Belikova, N. A., Vlasova, I.
I., et al. (2007). Cardiolipin switch in mitochondria: shutting off the reduction
of cytochrome c and turning on the peroxidase activity. Biochemistry 46,
3423–3434. doi: 10.1021/bi061854k
Bender, T., Lewrenz, I., Franken, S., Baitzel, C., and Voos, W. (2011).
Mitochodnrial enzymes are protected from stress-induced aggregation by
mitochondrial chaperones and the Pim1/LON protease. Mol. Biol. Cell 22,
541–554. doi: 10.1091/mbc.E10-08-0718
Bhosale, G., Sharpe, J. A., Sundier, S. Y., and Duchen, M. R. (2015). Calcium
signaling as a mediator of cell energy demand a trigger to cell death. Ann. N.Y.
Acad. Sci. 1350, 107–116. doi: 10.1111/nyas.12885
Birsoy, K., Wang, T., Chen, W. W., Freinkman, E., Abu-Remaileh, M., and
Sabatini, D.M. (2015). An essential role of the mitochondrial electron transport
chain in cell proliferation is to enable aspartate synthesis.Cell 162, 540–551. doi:
10.1016/j.cell.2015.07.016
Biswas, G., Adebanjo, O. A., Freedman, B. D., Anandatheerthavarada, H. K.,
Vijayasarathy, C., Zaidi, M., et al. (1999). Retrograde Ca2+ signaling in
C2C12 skeletal myocytes in response to mitochondrial genetic and metabolic
stress: a novel mode of inter-organelle crosstalk. EMBO J. 18, 522–533. doi:
10.1093/emboj/18.3.522
Bohovych, I., Chan, S. S., and Khalimonchuk, O. (2015). Mitochondrial protein
quality control: the mechanisms guarding mitochondrial health. Antioxid.
Redox Signal. 22, 977–994. doi: 10.1089/ars.2014.6199
Bohovych, I., Kastora, S., Christianson, S., Topil, D., Kim, H., Fangman, T., et al.
(2016). Oma1 links mitochondrial protein quality control and TOR signaling
to modulate physiological plasticity and cellular stress responses.Mol. Cell Biol.
36, 2300–2312. doi: 10.1128/MCB.00156-16
Brandes, S. N., and Jakob, U. (2009). Thiol-based redox switches in eukaryotic
proteins. Antioxid. Redox Signal. 11, 997–1014. doi: 10.1089/ars.2008.2285
Butow, R. A., and Avadhani, N. G. (2004). Mitochondrial signaling: the retrograde
response.Mol. Cell 14, 1–15. doi: 10.1016/S1097-2765(04)00179-0
Canto, C., Menzies, K. J., and Auwerx, J. (2015). NAD(+) metabolism and the
control of energy homeostasis: a balancing act between mitochondria and the
nucleus. Cell Metab. 22, 31–53. doi: 10.1016/j.cmet.2015.05.023
Carp, H. (1982). Mitochondrial N-formylmethionyl proteins as chemoattractants
for neutrophils. J. Exp. Med. 155, 264–275. doi: 10.1084/jem.155.1.264
Chacinska, A., Koehler, C. M., Milencovic, D., Lithgow, T., and Pfanner, N. (2009).
Importing mitochondrial proteins: machineries and mechanisms. Cell 138,
628–644. doi: 10.1016/j.cell.2009.08.005
Chandel, N. S. (2014). Mitochondria as signaling organelles. BMC Biol. 12:34. doi:
10.1186/1741-7007-12-34
Choi, S. Y., Gonsalvez, F., Jenkins, G. M., Stomianny, C., Chretein, D., Arnoult,
D., et al. (2007). Cardiolipin deficiency releases cytochrome c from the inner
mitochondrial membrane and accelerates stimuli-elicited apoptosis. Cell Death
Differ. 14, 597–606. doi: 10.1038/sj.cdd.4402020
Choudhary, C., Kumar, C., Gnad, F., Nielsen, M. L., Rehman, M., Walther, T.
C., et al. (2009). Lysine acetylation targets protein complexes and co-regulates
major cellular functions. Science 325, 834–840. doi: 10.1126/science.1175371
Chu, C. T., Ji, J., Dagda, R. K., Jiang, J. F., Tyurina, Y. Y., Kapralov, A. A., et al.
(2013). Cardiolipin externalization to the outer mitochondrial membrane acts
as an elimination signal for mitophagy in neuronal cells. Nat. Cell Biol. 15,
1197–1205. doi: 10.1038/ncb2837
Cirulli, E. T., Lasseigne, B. N., Petrovski, S., Sapp, P. C., Dion, P. A., Leblond, C. S.,
et al. (2015). Exome sequencing in amyotrophic lateral sclerosis identifies risk
genes and pathways. Science 347, 1436–1441. doi: 10.1126/science.aaa3650
Cobb, L. J., Lee, C., Xiao, J., Yen, K., Wong, R. G., Nakamura, H. K., et al.
(2016). Naturally occurring mitochondrial-derived peptides are age-dependent
regulators of apoptosis, insulin sensitivity, and inflammatory markers. Aging 8,
796–809. doi: 10.18632/aging.100943
Collins, Y., Chouchani, E. T., James, A. M., Menger, K. E., Cocheme, H. M., and
Murphy, M. P. (2012). Mitochondrial redox signaling at a glance. J. Cell Sci.
125, 801–806. doi: 10.1242/jcs.098475
Connor, K. M., Subbaram, S., Regan, K. J., Nelson, K. K., Mazurkiewicz, J.
E., Bartholomew, P. J., et al. (2005). Mitochondrial H2O2 regulates the
angiogenic phenotype via PTEN oxidation. J. Biol. Chem. 280, 16916–16924.
doi: 10.1074/jbc.M410690200
Corcoran, A., and Cotter, T. G. (2013). Redox regulation of protein kinases. FEBS
J. 280, 1944–1965. doi: 10.1111/febs.12224
Couvillion, M. T., Soto, I. C., Shipkovenska, G., and Churchman, L. S. (2016).
Synchronized mitochondrial and cytosolic translation programs. Nature 533,
499–503. doi: 10.1038/nature18015
Denu, J., and Tanner, K. G. (1998). Specific and reversible inactivation of
protein tyrosine phosphatases by hydrogen peroxide: evidence for a sulfenic
acid intermediate and implications for redox regulation. Biochemistry 37,
5633–5642. doi: 10.1021/bi973035t
DiMauro, S., and Schon, E. A. (2003). Mitochondrial respiratory chain diseases. N.
Engl. J. Med. 348, 2656–2668. doi: 10.1056/NEJMra022567
Egan, D. F., Shackelford, D. B., Mihaylova, M. M., Gelino, S., Kohnz, R. A.,
Mair, W., et al. (2011). Phosphorylation of ULK1 (hATG1) by AMP-activated
protein kinase connects energy sensing tomitophagy. Science 331, 456–461. doi:
10.1126/science.1196371
Eisenberg, T., Schroeder, S., Andryushkova, A., Pendl, T., Küttner, V., Bhukel,
A., et al. (2014). Nucleocytosolic depletion of the energy metabolite acetyl-
coenzyme A stimulates autophagy and prolongs lifespan. Cell Metab. 19,
431–444. doi: 10.1016/j.cmet.2014.02.010
Elliot, E., and Sutterwala, F. (2015). Initiation and perpetuation of NLRP3
inflammasome activation and assembly. Immunol. Rev. 265, 35–52. doi:
10.1111/imr.12286
Erickson, J. R., Joiner, M. A., Guan, X., Kutschke, W., Yang, J., Oddis, C. V., et al.
(2008). A dynamic pathway for calcium-independent activation of CaMKII by
methionine oxidation. Cell 133, 462–474. doi: 10.1016/j.cell.2008.02.048
Evans, D. R., and Guy, H. I. (2004). Mammalian pyrimidine biosynthesis: fresh
insights into an ancient pathway. J. Biol. Chem. 279, 33035–33038. doi:
10.1074/jbc.R400007200
Fang, C., Wei, X., and Wei, Y. (2016). Mitochondrial DNA in the regulation
of innate immune responses. Protein Cell 7, 11–16. doi: 10.1007/s13238-015-
0222-9
Figueira, T. R., Barros, M. H., Camargo, A. A., Castilho, R. F., Ferreira, J. C.,
Kowaltowski, A. J., et al. (2013). Mitochodnria asa source of reactive oxygen
and nitrogen species: from molecular mechanisms to human health. Antioxid.
Redox Signal. 18, 2029–2074. doi: 10.1089/ars.2012.4729
Finkel, T. (2011). Signal transduction by reactive oxygen species. J. Cell Biol. 194,
7–15. doi: 10.1083/jcb.201102095
García-Santamarina, S., Boronat, S., and Hidalgo, E. (2014). Reversible cysteine
oxidation in hydrogen peroxide sensing and signal transduction. Biochemistry
53, 2560–2580. doi: 10.1021/bi401700f
Garrido, C., Galluzzi, L., Brunet, M., Puig, P. E., Didelot, C., and Kroemer, G.
(2006). Mechanisms of cytochrome c release from mitochondria. Cell Death
Differ. 13, 1423–1433. doi: 10.1038/sj.cdd.4401950
Gaude, E., and Frezza, C. (2014). Defects in mitochondrial metabolism and cancer.
Cancer Metab. 2:10. doi: 10.1186/2049-3002-2-10
Goldstein, J. C., Waterhouse, N. J., Juin, P., Evan, G. I., and Green, D. R. (2000).
The coordinate release of cytochrome c during apoptosis is rapid, complete and
kinetically invariant. Nat. Cell Biol. 2, 156–162. doi: 10.1038/35004029
Gonzalvez, F., Schug, Z. T., Houtkooper, R. H., MacKenzie, E. D., Brooks, D.
G., Wanders, R. J., et al. (2008). Cardiolipin provides an essential activating
Frontiers in Cell and Developmental Biology | www.frontiersin.org 12 October 2016 | Volume 4 | Article 109
Bohovych and Khalimonchuk Mitochondria-Mediated Signaling
platform for caspase-8 on mitochondria. J. Cell Biol. 183, 681–696. doi:
10.1083/jcb.200803129
Guo, B., Zhai, D., Cabezas, E., Welsh, K., Nouraini, S., Satterthwait, A. C.,
et al. (2003). Humanin peptide suppresses apoptosis by interfering with Bax
activation. Nature 423, 456–461. doi: 10.1038/nature01627
Guzy, R. D., Hoyos, B., Robin, E., Chen, H., Liu, L., Mansfield, K. D.,
et al. (2005). Mitochondrial complex III is required for hypoxia-induced
ROS production and cellular oxygen sensing. Cell Metab. 1, 401–408. doi:
10.1016/j.cmet.2005.05.001
Hall, J. A., Dominy, J. E., Lee, Y., and Puigserver, P. (2013). AMP-activated protein
kinase: an energy sensor that regulates all aspects of cell function. J. Clin. Invest.
123, 973–979. doi: 10.1172/JCI64094
Hamanaka, R. B., and Chandel, N. S. (2010). Mitochondrial reactive oxygen species
regulate cellular signaling and dictate biological outcomes. Trends Biol. Sci. 35,
505–513. doi: 10.1016/j.tibs.2010.04.002
Hardie, D. G., Schaffer, B. E., and Brunet, A. (2016). AMPK: an energy-sensing
pathway with multiple inputs and outputs. Trends Cell Biol. 26, 190–201. doi:
10.1016/j.tcb.2015.10.013
Harman, D. (1972). The biologic clock: the mitochondria? J. Am. Geriatr. Soc. 20,
145–147. doi: 10.1111/j.1532-5415.1972.tb00787.x
Haynes, C. M., Fiorese, C. J., and Lin, Y. F. (2013). Evaluating and responding to
mitochondrial dysfunction: the mitochondrial unfolded protein response and
beyond. Trends Cell Biol. 23, 311–318. doi: 10.1016/j.tcb.2013.02.002
Haynes, C. M., Yang, Y., Blais, S. P., Neubert, T. A., and Ron, D. (2010). The
matrix peptide exporter HAF-1 signals a mitochondrial UPR by activating
the transcription factor ZC376.7 in C. elegans. Mol. Cell 37, 529–540. doi:
10.1016/j.molcel.2010.01.015
Heo, J. M., Ordureau, A., Paulo, J. A., Rinehart, J., and Harper, J. W. (2015). The
PINK1-PARKIN mitochondrial ubiquitylation pathway drives a program of
OPTN/NDP52 recruitment and TBK1 activation to promote mitophagy. Mol.
Cell 60, 7–20. doi: 10.1016/j.molcel.2015.08.016
Hess, D. T., Matsumoto, A., Kim, S. O., Marshall, H. E., and Stamler, J. S. (2005).
Protein s-nitorsylation: purview and parameters. Nat. Rev. Mol. Cell Biol. 6,
150–166. doi: 10.1038/nrm1569
Hokari, Y., Seki, T., Nakano, H., Matsuo, Y., Fukamizu, A., Munekata, E., et al.
(2012). Isolation and identification of novel neutrophil-activating cryptides
hidden in mitochondrial cytochrome C. Protein Pept. Lett. 19, 680–687. doi:
10.2174/092986612800494048
Horibe, T., and Hoogenraad, N. J. (2007). The chop gene contains an element for
the positive regulation of the mitochondrial unfolded protein response. PLoS
ONE 2:e835. doi: 10.1371/journal.pone.0000835
Hsu, O., Liu, X., Zhang, J., Wang, H. G., Ye, J. M., and Shi, Y. (2015).
Cardiolipin remodeling by TAZ/tafazzin is selectively required for the initiation
of mitophagy. Autophagy 11, 643–652. doi: 10.1080/15548627.2015.1023984
Hüttemann, M., Pecina, P., Rainbolt, M., Sanderson, T. H., Kagan, V. E., Samavati,
L., et al. (2011). The multiple functions of cytochrome c and their regulation in
life and death decisions of the mammalian cell: from respiration to apoptosis.
Mitochondrion 11, 369–381. doi: 10.1016/j.mito.2011.01.010
Iyer, S. S., He, Q., Janczy, J. R., Elliott, E. I., Zhong, Z., Olivier, A. K., et al. (2013).
Mitochondrial cardiolipin is required for Nlrp3 inflammasome activation.
Immunity 39, 311–323. doi: 10.1016/j.immuni.2013.08.001
Jain, I. H., Zazzeron, L., Goli, R., Alexa, K., Schatzman-Bone, S., Dhillon, H., et al.
(2016). Hypoxia as a therapy for mitochondrial disease. Science 352, 54–61. doi:
10.1126/science.aad9642
Jin, S. M., Lazarou, M., Wang, C., Kane, L. A., Narendra, D. P., and Youle,
R. J. (2010). Mitochondrial membrane potential regulates PINK1 import
and proteolytic destabilization by PARL. J. Cell Biol. 191, 933–942. doi:
10.1083/jcb.201008084
Kagan, V. E., Tyurin, V. A., Jiang, J., Tyurina, Y. Y., Ritov, V. B., Amoscato, A. A.,
et al. (2005). Cytochrome c acts as a cardiolipin oxygenase required for release
of proapoptotic factors.Nat. Chem. Biol. 1, 223–232. doi: 10.1038/nchembio727
Kagan, V. E., Tyurina, Y. Y., Tyurin, V. A., Mohammadyani, D., Angeli, J.
P., Baranov, S. V., et al. (2015). Cardiolipin signaling mechanisms: collapse
of asymmetry and oxidation. Antioxid. Redox Signal. 22, 1667–1680. doi:
10.1089/ars.2014.6219
Kane, L. A., Lazarou, M., Fogel, A. I., Li, Y., Yamano, K., Sarraf, S. A., et al. (2014).
PINK1 phosphorylates ubiquitin to activate Parkin E3 ubiquitin ligase activity.
J. Cell Biol. 205, 143–153. doi: 10.1083/jcb.201402104
Kazlauskaite, A., Kondapalli, C., Gourlay, R., Campbell, D. G., Ritorto, M.
S., Hofmann, K., et al. (2014). Parkin is activated by PINK1-dependent
phosphorylation of ubiquitin at Ser65. Biochem. J. 460, 127–139. doi:
10.1042/BJ20140334
Khutorenko, A. A., Roudko, V. V., Chernyak, B. V., Vartapetian, A. B., Chumakov,
P.M., and Evstafieva, A. G. (2010). Pyrimidine biosynthesis linksmitochondrial
respiration to the p53 pathway. Proc. Natl. Acad. Sci. U.S.A. 107, 12828–12833.
doi: 10.1073/pnas.0910885107
Kim, J., Kundu, M., Viollet, B., and Guan, K. L. (2011). AMPK and mTOR regulate
autophagy through direct phosphorylation of Ulk1. Nat. Cell Biol. 13, 132–141.
doi: 10.1038/ncb2152
Kondapalli, C., Kazlauskaite, A., Zhang, N., Woodroof, H. I., Campbell,
D. G., Gourlay, R., et al. (2012). PINK1 is activated by mitochondrial
membrane potential depolarization and stimulates Parkin E3 ligase activity by
phosphorylating Serine 65. Open Biol. 2:120080. doi: 10.1098/rsob.120080
Koyano, F., Okatsu, K., Kosako, H., Tamura, Y., Go, E., Kimura, M., et al. (2014).
Ubiquitin is phosphorylated by PINK1 to activate parkin.Nature 520, 162–166.
doi: 10.1038/nature13392
La Rovere, R. M., Roest, G., Bultynck, G., and Parys, J. B. (2016). Intracellular Ca2+
signaling and Ca2+ microdomains in the control of cell survival, apoptosis and
autophagy. Cell Calcium. 60, 74–87. doi: 10.1016/j.ceca.2016.04.005
Lazarou, M., Sliter, D. A., Kane, L. A., Sarraf, S. A., Wang, C., Burman, J. L., et al.
(2015). The ubiquitin kinase PINK1 recruits autophagy receptors to induce
mitophagy. Nature 524, 309–314. doi: 10.1038/nature14893
Lee, C., Kim, K. H., and Cohen, P. (2016). MOTS-c: a novel mitochondrial-
derived peptide regulating muscle and fat metabolism. Free Radic. Biol. Med.
doi: 10.1016/j.freeradbiomed.2016.05.015. [Epub ahead of print].
Lee, C., Yen, K., and Cohen, P. (2013). Humanin: a harbinger of
mitochondrial-derived peptides? Trends Endocrinol. Metab. 24, 222–228.
doi: 10.1016/j.tem.2013.01.005
Lee, C., Zeng, J., Drew, B. G., Sallam, T., Martin-Montalvo, A.,Wan, J., et al. (2015).
The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis
and reduces obesity and insulin resistance. Cell Metab. 21, 443–454. doi:
10.1016/j.cmet.2015.02.009
Liao, X., and Butow, R. A. (1993). RTG1 and RTG2: two yeast genes required for a
novel path of communication frommitochondria to the nucleus.Cell 72, 61–71.
doi: 10.1016/0092-8674(93)90050-Z
Lin, Y. F., and Haynes, C. M. (2016). Metabolism and UPR(mt). Mol. Cell 61,
677–682. doi: 10.1016/j.molcel.2016.02.004
Lin, Y. F., Schulz, A. M., Pellegrino, M. W., Lu, Y., Shaham, S., and Haynes, C. M.
(2016). Maintenance and propagation of a deleterious mitochondrial genome
be the mitochondrial unfolded protein response. Nature 533, 416–419. doi:
10.1038/nature17989
Liu, X., Kim, C. N., Yang, J., Jemmerson, R., and Wang, X. (1996). Induction of
apoptotic program in cell-free extracts: requirement for dATP and cytochrome
c. Cell 86, 147–157. doi: 10.1016/S0092-8674(00)80085-9
Liu, Z., and Butow, R. A. (1999). A transcriptional switch in the expression
of yeast tricarboxylic acid cycle genes in response to a reduction or loss of
respiratory function. Mol. Cell. Biol. 19, 6720–6728. doi: 10.1128/MCB.19.
10.6720
Losman, J. A., and Kaelin, W. G. (2013). What a difference a hydroxyl makes:
mutant IDH, (R)-2-hydroxyglutarate, and cancer. Genes Dev. 27, 836–852. doi:
10.1101/gad.217406.113
Lu, Y. W., and Claypool, S. M. (2015). Disorders of phospholipid metabolism: an
emerging class of mitochondrial disease due to defects in nuclear genes. Front.
Genet. 6:3. doi: 10.3389/fgene.2015.00003
Maruyama, H., Morino, H., Ito, H., Izumi, Y., Kato, H., Watanabe, Y., et al.
(2010). Mutations of optineurinin in amyotrophic lateral sclerosis. Nature 465,
223–226. doi: 10.1038/nature08971
Michel, S., Canonne, M., Arnould, T., and Renard, P. (2015). Inhibition of
mitochondrial genome expression triggers the activation of CHOP-10 by
a cell signaling dependent on the integrated stress response but not the
mitochondrial unfolded protein response. Mitochondrion 21, 58–68. doi:
10.1016/j.mito.2015.01.005
Moisoi, N., Klupsch, K., Fedele, V., East, P., Sharma, S., Renton, A., et al.
(2009). Mitochondrial dysfunction triggered by loss of HtrA2 results in the
activation of a brain-specific transcriptional stress response. Cell Death Differ.
16, 449–464. doi: 10.1038/cdd.2008.166
Frontiers in Cell and Developmental Biology | www.frontiersin.org 13 October 2016 | Volume 4 | Article 109
Bohovych and Khalimonchuk Mitochondria-Mediated Signaling
Mukai, H., Seki, T., Nakano, H., Hokari, Y., Takao, T., Kawanami, M., et al.
(2009). Mitocryptide-2: purification, identification, and characterization of a
novel cryptide that activates neutrophils. J. Immunol. 182, 5072–5080. doi:
10.4049/jimmunol.0802965
Murphy, M. P. (2009). How mitochondria produce reactive oxygen species.
Biochem J. 417, 1–13. doi: 10.1042/BJ20081386
Nagata, S. (2016). Cell biology: killer enzymes tethered. Nature 533, 474–476. doi:
10.1038/nature18439
Nakamura, T., Tu, S., Akhtar, M. W., Sunico, C. R., Okamoto, S., and Lipton, S. A.
(2013). Aberrant protein s-nitrosylation in neurodegenerative diseases. Neuron
78, 596–614. doi: 10.1016/j.neuron.2013.05.005
Nargund, A. M., Fiorese, C. J., Pellegrino, M. W., Deng, P., and Haynes, C. M.
(2015). Mitochondrial and nuclear accumulation of the transcription factor
ATFS-1 promotes OXPHOS recovery during the UPR(mt). Mol. Cell 58,
123–133. doi: 10.1016/j.molcel.2015.02.008
Nargund, A. M., Pellegrino, M. W., Fiorese, C. J., Baker, B. M., and Haynes, C.
M. (2012). Mitochondrial import efficiency of ATFS-1 regulates mitochondrial
UPR activation. Science 337, 587–590. doi: 10.1126/science.1223560
Neupert, W., and Herrmann, J. M. (2007). Translocation of proteins
into mitochondria. Annu. Rev. Biochem. 76, 723–749. doi:
10.1146/annurev.biochem.76.052705.163409
Neuspiel, M., Schauss, A. C., Braschi, E., Zunino, R., Rippstein, P., Rachubinski,
R. A., et al. (2008). Cargo-selected transport from the mitochondria to
peroxisomes is mediated by vesicular carriers. Curr. Biol. 18, 102–108. doi:
10.1016/j.cub.2007.12.038
Nikkanen, J., Forsström, S., Euro, L., Paetau, I., Kohnz, R. A., Wang, L.,
et al. (2016). Mitochondrial DNA replication defects disturb cellular dNTP
pools and remodel one-carbon metabolism. Cell Metab. 23, 635–648. doi:
10.1016/j.cmet.2016.01.019
Nisoli, E., Clementi, E., Paolucci, C., Cozzi, V., Tonello, C., Sciorati, C., et al. (2003).
Mitochondrial biogenesis in mammals: the role of endogenous nitric oxide.
Science 299, 896–899. doi: 10.1126/science.1079368
Ordureau, A., Sarraf, S. A., Duda, D. M., Heo, J. M., Jedrychowski, M. P.,
Sviderskiy, V. O., et al. (2014). Quantitative proteomics of reveal a feedforward
mechanism for mitochondrial PARKIN translocation and ubiquitin chain
synthesis.Mol. Cell 56, 360–375. doi: 10.1016/j.molcel.2014.09.007
Ott, M., Amunts, A., and Brown, A. (2016). Organization and regulation of
mitochondrial protein synthesis. Annu. Rev. Biochem. 85, 1.1–1.25. doi:
10.1146/annurev-biochem-060815-014334
Ott, M., Robertson, J. D., Gogvadze, V., Zhitovsky, B., and Orrenius, S. (2002).
Cytochrome c release from mitochondria proceeds by a two-step process. Proc.
Natl. Acad. Sci. U.S.A. 99, 1259–1263. doi: 10.1073/pnas.241655498
Pan, Y., Schroeder, E. A., Ocampo, A., Barrientos, A., and Shadel, G.
S. (2011). Regulation of yeast chronological life span by TORC1 via
adaptivemitochondrial ROS signaling. Cell Metab. 13, 668–678. doi:
10.1016/j.cmet.2011.03.018
Parker, S. J., and Metallo, C. M. (2015). Metabolic consequences
of oncogenic IDH mutations. Pharmacol. Ther. 152, 54–62. doi:
10.1016/j.pharmthera.2015.05.003
Patterson, H. C., Gerbeth, C., Thiru, P., Vogtle, N. F., Knoll, M., Shahsafaei, A.,
et al. (2015). A respiratory chain controlled signal transduction cascade in the
mitochondrial intermembrane space mediates hydrogen peroxide signaling.
Proc. Natl. Acad. Sci. U.S.A. 112, E5679–E5688. doi: 10.1073/pnas.15179
32112
Pearce, E. L., Poffenberger, M. C., Chang, C. H., and Jones, R. G. (2013). Fueling
immunity: insights into metabolism and lymphocyte function. Science 342,
1242454. doi: 10.1126/science.1242454
Pellegrino, M., Nargund, A., and Haynes, C. M. (2013). Signaling the
mitochondrial unfolded protein response. Biochim. Biophys. Acta 1833,
410–416. doi: 10.1016/j.bbamcr.2012.02.019
Pickrell, A. M., and Youle, R. J. (2015). The roles of PINK1, parkin and
mitochondrial fidelity in Parkinson’s disease. Neuron 85, 257–273. doi:
10.1016/j.neuron.2014.12.007
Rabiet, M. J., Huet, E., and Boulay, F. (2005). Human mitochondria-derived N-
formylated peptides are novel agonists equally active on FPR and FPRL1,
while Listeria monocytogenes-derived peptides preferentially activate FPR. Eur.
J. Immunol. 35, 2486–2495. doi: 10.1002/eji.200526338
Rabiet, M. J., Huet, E., and Boulay, F. (2007). The N-formyl peptide receptors and
the anaphylatoxin C5a receptors: an overview. Biochimie 89, 1089–1106. doi:
10.1016/j.biochi.2007.02.015
Reubold, T. F., and Eschenburg, S. (2012). A molecular view on signal
transduction by the apoptosome. Cell Signal. 24, 1420–1425. doi:
10.1016/j.cellsig.2012.03.007
Richter, U., Lahtinen, T., Marttinen, P., Myohanen, M., Greco, D., Cannini, G.,
et al. (2013). A mitochondrial ribosomal and RNA decay pathway blocks cell
proliferation. Curr. Biol. 23, 535–541. doi: 10.1016/j.cub.2013.02.019
Rizzuto, R., De Stefani, D., Raffaello, A., andMammucari, C. (2012). Mitochondria
as sensors and regulators of calcium signalling. Nat. Rev. Mol. Cell Biol. 13,
566–578. doi: 10.1038/nrm3412
Russell, E. G., and Cotter, T. G. (2015). New insight into the role of Reactive
Oxygen Species (ROS) in cellular signal-transduction processes. Int. Rev. Cell
Mol. Biol. 319, 221–254. doi: 10.1016/bs.ircmb.2015.07.004
Sabrassov, D. D., and Sabatini, D. M. (2005). Redox regulation of the
nutrient-sensitive Raptor-mTOR pathway and complex. J. Biol. Chem. 280,
39505–39509. doi: 10.1074/jbc.M506096200
Sarraf, S. A., Raman,M., Guarani-Pereira, V., Sowa,M. E., Huttlin, E. L., Gygi, S. P.,
et al. (2013). Landscape of the PARKIN-dependent ubiquitylome in response to
mitochondrial depolarization. Nature 496, 372–376. doi: 10.1038/nature12043
Seiferling, D., Szczepanowska, K., Becker, C., Senft, K., Hermans, S., Maiti,
P., et al. (2016). Loss of CLPP alleviates mitochondrial cardiomyopathy
without affecting the mammalian UPRmt. EMBO Rep. 17, 953–964. doi:
10.15252/embr.201642077
Seki, T., Fukamizu, A., Kiso, Y., and Mukai, H. (2011). Mitocryptide-2, a
neutrophil-activating cryptide, is a specific endogenous agonist for formyl-
peptide receptor-like 1. Biochem. Biophys. Res. Commun. 404, 482–487. doi:
10.1016/j.bbrc.2010.12.007
Sena, L. A., and Chandel, N. S. (2012). Physiological roles of mitochondrial reactive
oxygen species.Mol. Cell 48, 158–167. doi: 10.1016/j.molcel.2012.09.025
Sevrioukova, I. F. (2011). Apoptosis-inducing factor: structure, function, and redox
regulation. Antioxid. Redox Signal. 14, 2545–2579. doi: 10.1089/ars.2010.3445
Shadel, G. S., and Horvath, T. L. (2015). Mitochondrial ROS signaling in
organismal homeostasis. Cell 163, 560–569. doi: 10.1016/j.cell.2015.10.001
Shimada, K., Crother, T. R., Karlin, J., Dagvadorj, J., Chiba, N., Chen, S., et al.
(2012). Oxidized mitochondrial DNA activates the NLRP3 inflammasome
during apoptosis. Immunity 36, 401–414. doi: 10.1016/j.immuni.2012.01.009
Siekvitz, P. (1957). Powerhouse of the cell. Sci. Am. 197, 131–144. doi:
10.1038/scientificamerican0757-131
Spange, S., Wagner, T., Heinzel, T., and Kramer, O. H. (2009). Acetylation of non-
histone proteins modulates cellular signaling at multiple levels. Int. J. Biochem.
Cell Biol. 41, 185–198. doi: 10.1016/j.biocel.2008.08.027
Sugiura, A., McLelland, G. L., Fon, E. A., and McBride, H. M. (2012). A new
pathway for mitochondrial quality control: mitochondria-derived vesicles.
EMBO J. 33, 2142–2156. doi: 10.15252/embj.201488104
Sullivan, L. B., Gui, D. Y., Hosiso, A. M., Bush, L. N., Freinkman, E., and
Vander Heiden, M. G. (2015). Supporting aspartate biosynthesis is an
essential function of respiration in proliferating cells. Cell 162, 552–563. doi:
10.1016/j.cell.2015.07.017
Sullivan, L. B., Martinez-Garcia, E., Nguyen, H., Mullen, A. R., Dufour, E.,
Sudarshan, S., et al. (2013). The proto-oncometabolite fumarate binds
glutathione to amplify ROS-dependent signaling. Mol. Cell 51, 236–248. doi:
10.1016/j.molcel.2013.05.003
Tait, S. W. G., and Green, D. R. (2010). Mitochondria and cell death: outer
membrane permeabilization and beyond. Nat. Rev. Mol. Cell Biol. 11, 621–632.
doi: 10.1038/nrm2952
Takeuchi, A., Kim, B., and Matsuoka, S. (2015). The destiny of Ca2+ released by
mitochondria. J. Physiol. Sci. 65, 11–24. doi: 10.1007/s12576-014-0326-7
Tanner, J. J., Parsons, Z. D., Cummings, A. H., Zhou, H., and Gates, K. S. (2011).
Redox regulation of protein tyrosine phosphatases: structural and chemical
aspects. Antioxid. Redox Signal. 15, 77–97. doi: 10.1089/ars.2010.3611
Tian, Y., Garcia, G., Bian, Q., Steffen, K. K., Joe, L., Wolff, S., et al. (2016).
Mitochondrial stress induces chromatin reorganization to promote longevity
and UPR(mt). Cell 165, 1197–1208. doi: 10.1016/j.cell.2016.04.011
Tidow, H., and Nisse, P. (2013). Structural diversity of calmodulin binding to its
target sites. FEBS J. 280, 5551–5565. doi: 10.1111/febs.12296
Frontiers in Cell and Developmental Biology | www.frontiersin.org 14 October 2016 | Volume 4 | Article 109
Bohovych and Khalimonchuk Mitochondria-Mediated Signaling
Topf, U., Wrobel, L., and Chacinska, A. (2016). Chatty mitochondria: keeping
balance in cellular protein homeostasis. Trends Cell. Biol. 26, 577–586. doi:
10.1016/j.tcb.2016.03.002
Toyama, E. Q., Herzig, S., Courchet, J., Lewis, T. L. Jr., Loson, O. C., Hellberg,
K., et al. (2016). AMP-activated protein kinase mediates mitochondrial fission
in response to energy stress. Science 351, 275–281. doi: 10.1126/science.aa
b4138
Truong, T. H., and Carroll, K. S. (2013). Redox regulation of protein kinases. Crit.
Rev. Biochem. Mol. Biol. 48, 332–356. doi: 10.3109/10409238.2013.790873
Tsai, S. J., Sen, U., Zhao, L., Greenleaf, W., Dasgupta, J., Fiorillo, E., et al.
(2009). Crystal structure of the human lymphoid tyrosine phosphatase catalytic
domain: insights into redox regulation. Biochemistry 48, 4838–4845. doi:
10.1021/bi900166y
Tyynismaa, H., Carroll, C. J., Raimundo, N., Ahola-Erkkila, S., Wenz, T., Ruhanen,
H., et al. (2010). Mitochondrial myopathy induces a starvation-like response.
Hum. Mol. Genet. 19, 3948–3958. doi: 10.1093/hmg/ddq310
Vafai, S. B., andMootha, V. K. (2012). Mitochondrial disorders as windows into an
ancient organelle. Nature 491, 374–383. doi: 10.1038/nature11707
Verdin, E. (2015). NAD+ in aging, metabolism and neurodegeneration. Science
350, 1208–1213. doi: 10.1126/science.aac4854
Wallace, D. C. (2005). A mitochondrial paradigm of metabolic and degenerative
diseases, aging and cancer: a dawn for evolutionarymedicine.Annu. Rev. Genet.
39, 359–407. doi: 10.1146/annurev.genet.39.110304.095751
Wang, X., and Chen, X. J. (2015). A cytosolic network suppressing mitochondria-
mediated proteostatic stress and cell death. Nature 524, 481–484. doi:
10.1038/nature14859
Wellen, K. E., Hatzivassiliou, G., Sachdeva, U. M., Bui, T. V., Cross, J. R., and
Thompson, C. B. (2009). ATP-citrate lyase links cellular metabolism to histone
acetylation. Science 324, 1076–1080. doi: 10.1126/science.1164097
West, A. P., Khoury-Hanold, W., Staron, M., Tal, M. C., Pineda, C. M., Lang, S. M.,
et al. (2015). Mitochondrial DNA stress primes the antiviral innate immune
response. Nature 520, 553–557. doi: 10.1038/nature14156
Wong, Y. C., and Holzbaur, E. L. (2014). Optineurin is an autophagy receptor
for damaged mitochondria in parkin-mediated mitophagy that is disrupted by
an ALS-linked mutation. Proc. Natl. Acad. Sci. U.S.A. 111, E4439–E4448. doi:
10.1073/pnas.1405752111
Wrobel, L., Topf, U., Bragoszewski, P., Wiese, S., Sztolsztener, M. E., Oelieklaus,
S., et al. (2015). Mistargeted mitochondrial proteins activate a proteostatic
response in the cytosol. Nature 524, 485–488. doi: 10.1038/nature14951
Xun, Z., Rivera-Sanchez, S., Ayala-Pena, S., Lim, J., Budworth, H., Skoda, E. M.,
et al. (2012). Targeting of XJB-5-131 tomitochondria suppresses oxidative DNA
damage and motor decline in a mouse model of Huntington’s disease. Cell Rep.
2, 1137–1142. doi: 10.1016/j.celrep.2012.10.001
Xu, W., Yang, H., Liu, Y., Yang, Y., Wang, P., Kim, S. H., et al. (2011).
Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of a-
ketoglutarate-dependent dioxygenases. Cancer Cell 19, 17–30. doi:
10.1016/j.ccr.2010.12.014
Young, M. J., and Copeland, W. C. (2016). Human mitochondrial DNA
replication machinery and disease. Curr. Opin. Genet. Dev. 38, 52–62. doi:
10.1016/j.gde.2016.03.005
Zhang, H., Ryu, D., Wu, Y., Gariani, K., Wang, X., Luan, P., et al. (2016). NAD+
repletion improvesmitochondrial and stem cell function and enhances life span
in mice. Science 352, 1436–1443. doi: 10.1126/science.aaf2693
Zhang, Q., Raoof, M., Chen, Y., Sumi, Y., Sursal, T., Junger, W., et al. (2010).
Circulating mitochondrial DAMPs cause inflammatory responses to injury.
Nature 464, 104–107. doi: 10.1038/nature08780
Zhang, Z., Tan,M., Xie, Z., Dai, L., Chen, Y., and Zhao, Y. (2011). Identofocation of
lysine succinylation as a new post-translational modification. Nat. Chem. Biol.
7, 58–63. doi: 10.1038/nchembio.495
Zong, W. X., Rabinowitz, J. D., and White, E. (2016). Mitochondria and cancer.
Mol. Cell 61, 667–676. doi: 10.1016/j.molcel.2016.02.011
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2016 Bohovych and Khalimonchuk. This is an open-access article
distributed under the terms of the Creative Commons Attribution License (CC BY).
The use, distribution or reproduction in other forums is permitted, provided the
original author(s) or licensor are credited and that the original publication in this
journal is cited, in accordance with accepted academic practice. No use, distribution
or reproduction is permitted which does not comply with these terms.
Frontiers in Cell and Developmental Biology | www.frontiersin.org 15 October 2016 | Volume 4 | Article 109
